National Pension Service Has $133.74 Million Holdings in CVS Health Co. (NYSE:CVS)

National Pension Service increased its holdings in CVS Health Co. (NYSE:CVSFree Report) by 4.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,979,289 shares of the pharmacy operator’s stock after acquiring an additional 135,887 shares during the period. National Pension Service owned about 0.24% of CVS Health worth $133,740,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health in the 3rd quarter valued at about $25,000. Ridgewood Investments LLC increased its stake in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the last quarter. Stonebridge Financial Group LLC purchased a new stake in CVS Health in the 4th quarter valued at about $28,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health in the 3rd quarter valued at about $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health in the 3rd quarter valued at about $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Up 0.2 %

Shares of NYSE:CVS opened at $63.78 on Thursday. The firm has a fifty day moving average price of $53.48 and a two-hundred day moving average price of $56.34. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The company has a market cap of $80.42 billion, a price-to-earnings ratio of 17.43, a PEG ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.17%. The ex-dividend date was Thursday, January 23rd. CVS Health’s payout ratio is 72.68%.

Analyst Upgrades and Downgrades

Several research firms have commented on CVS. Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Truist Financial raised their price target on shares of CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Evercore ISI raised their price target on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. TD Cowen raised their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Finally, Wells Fargo & Company raised their price target on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $70.00.

Get Our Latest Analysis on CVS Health

Insider Activity

In related news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the transaction, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.24% of the company’s stock.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Further Reading

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.